2,045 active funding opportunities
Supports development and dissemination of computational tools to analyze dynamic brain circuits and understand neural mechanisms across scales.
Funds research education to enhance knowledge of substance use disorders for clinicians and clinical researchers.
Supports established investigators to build research and educational infrastructure in aging and Alzheimer's Disease without leading independent clinical trials.
Supports NINDS intramural neurologist- and neurosurgeon-scientists transitioning to independent faculty roles with research and clinical activities.
Supports NINDS intramural neurologist- and neurosurgeon-scientists transitioning to independent academic faculty positions with research and clinical activities.
Supports innovative multisite clinical trials and observational studies leveraging NICHD network infrastructure for women, children, pregnant/lactating women, and persons with disabilities.
Supports advanced pre-clinical research to translate nanotechnology-based cancer diagnostics and therapeutics for improved treatment.
Funds basic mechanistic research on biological/genetic causes of cancer health disparities, including new methods and secondary data analyses.
Supports research on novel newborn screening methods and therapies for fatal or disabling conditions and high priority genetic disorders.
Funds pilot projects to study understudied proteins linked to rare diseases, supporting preliminary data and tool development.
Funds research on novel newborn screening methods and therapies for fatal or disabling conditions, including high priority genetic disorders.
Funds basic research on harmful effects of acute exposure to ultra-potent synthetic opioids like fentanyl and carfentanil, including delayed pathophysiological impacts.
Supports foundational basic and applied research proposals to advance Army science and technology capabilities.
Supports innovative analysis of existing data to study drug use behaviors, prevention, and health service utilization.
Supports innovative analysis of existing data to study drug use behaviors, prevention, and health service utilization, excluding clinical trials.
Supports early translational research to identify and characterize therapeutic candidates for HLBS diseases, facilitating product development and entrepreneurship.
Funds early-stage medical device prototype design, disease target identification, and assay development for HLBS diseases to advance translational research.
Funds early translational research to identify therapeutic candidates and prototypes for HLBS diseases, advancing projects toward human testing readiness without clinical trials.
Funds early translational support for prototype testing and assay development targeting HLBS diseases to advance products toward in vivo testing readiness.
Funds validation of transformative platforms to accelerate detection, diagnosis, and treatment of HLBS diseases.
Funds Alaska Native entities to assess and remediate contamination on ANCSA lands, supporting health and economic recovery.
Supports Master Cooperative Agreements with CESU network participants for interdisciplinary research and resource stewardship across US biogeographic regions.
Funds innovative applied research proposals supporting Army modernization and readiness through data-driven analysis and technology development.
Funds renewal or revision of ongoing dental and craniofacial clinical trials to support planning and implementation activities.
